Results 201 to 210 of about 29,172 (262)
Role of tannin-rich plant fractions in hepatoprotection: a nanotechnology perspective. [PDF]
Discov NanoShende S, Patel J.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Drug Metabolism, 2018
With the rapid development of nanoparticles in drug delivery system, a lot of interest in the genotoxicity evaluation of nanocarriers has emerged currently. Here our emphasis was placed on the summary of studies on standard genotoxicity assays.We performed a PubMed/MEDLINE search for all publications in the English language related to assessment of ...
Ting, Luo +4 more
openaire +2 more sources
With the rapid development of nanoparticles in drug delivery system, a lot of interest in the genotoxicity evaluation of nanocarriers has emerged currently. Here our emphasis was placed on the summary of studies on standard genotoxicity assays.We performed a PubMed/MEDLINE search for all publications in the English language related to assessment of ...
Ting, Luo +4 more
openaire +2 more sources
Neuropsychological Disorders and their Nanocarriers
Current Pharmaceutical Design, 2020Neuropsychological disorders are now growing rapidly worldwide among the people of diverse backgrounds irrespective of age, gender, and geographical region. Such disorders not only disturb the normal life and functionality of an individual but also impact the social relationships of the patient and the people associated with them, and if not treated ...
Surbhi Sharma, Shweta Dang
openaire +2 more sources
Organic Letters, 2010
An approach to the design and fabrication of mechanized mesoporous silica nanoparticles is demonstrated at the proof of principle level. It relies on the reductive cleavage of disulfide bonds within an integrated nanosystem, wherein surface-bound rotaxanes incorporate disulfide bonds in their stalks, which are encircled by cucurbit[6]uril or alpha ...
Ambrogio, Michael W. +8 more
openaire +3 more sources
An approach to the design and fabrication of mechanized mesoporous silica nanoparticles is demonstrated at the proof of principle level. It relies on the reductive cleavage of disulfide bonds within an integrated nanosystem, wherein surface-bound rotaxanes incorporate disulfide bonds in their stalks, which are encircled by cucurbit[6]uril or alpha ...
Ambrogio, Michael W. +8 more
openaire +3 more sources
Journal of Nanosciences Research & Reports
Nanocarriers are one class of nanomaterials. They are finding increasing application in several realms, particularly as chemotherapeutic agents in the treatment of cancer. They have certain properties that allow them to fulfill their roles. Amongst these are their small size, large surface area, heavy loading and release of drug.
Zeeshan Rafi +3 more
openaire +2 more sources
Nanocarriers are one class of nanomaterials. They are finding increasing application in several realms, particularly as chemotherapeutic agents in the treatment of cancer. They have certain properties that allow them to fulfill their roles. Amongst these are their small size, large surface area, heavy loading and release of drug.
Zeeshan Rafi +3 more
openaire +2 more sources
Pharmaceutical Research, 2007
The use of nanoparticulate pharmaceutical carriers to enhance the in vivo efficiency of many drugs well established itself over the past decade both in pharmaceutical research and clinical setting. The current level of engineering pharmaceutical nanocarriers in some cases allows for drug delivery systems (DDS) to demonstrate a combination of some ...
openaire +2 more sources
The use of nanoparticulate pharmaceutical carriers to enhance the in vivo efficiency of many drugs well established itself over the past decade both in pharmaceutical research and clinical setting. The current level of engineering pharmaceutical nanocarriers in some cases allows for drug delivery systems (DDS) to demonstrate a combination of some ...
openaire +2 more sources
Nanocarriers and Their Loading Strategies
Advanced Healthcare Materials, 2018AbstractNanocarriers are of paramount significance for drug delivery and nanomedicine technology. Given the imperfect systems and nonideal therapeutic effects, there are works to be done in synthesis as much as in biological studies, if not more so.
Neng Wang +4 more
openaire +2 more sources
Advanced Drug Delivery Reviews, 2006
Currently used pharmaceutical nanocarriers, such as liposomes, micelles, nanoemulsions, polymeric nanoparticles and many others demonstrate a broad variety of useful properties, such as longevity in the blood allowing for their accumulation in pathological areas with compromised vasculature; specific targeting to certain disease sites due to various ...
openaire +2 more sources
Currently used pharmaceutical nanocarriers, such as liposomes, micelles, nanoemulsions, polymeric nanoparticles and many others demonstrate a broad variety of useful properties, such as longevity in the blood allowing for their accumulation in pathological areas with compromised vasculature; specific targeting to certain disease sites due to various ...
openaire +2 more sources
Injectable nanocarriers for biodetoxification
Nature Nanotechnology, 2007Hospitals routinely treat patients suffering from overdoses of drugs or other toxic chemicals as a result of illicit drug consumption, suicide attempts or accidental exposures. However, for many life-threatening situations, specific antidotes are not available and treatment is largely based on emptying the stomach, administering activated charcoal or ...
openaire +2 more sources
Current Drug Delivery, 2021
Background: Lipid nanocarriers have been widely tested as drug delivery systems to treat diseases due to their bioavailability, controlled release, and low toxicity. For the pulmonary route, the Food and Drug Administration favors the use of substances generally recognized as safe, as well as biodegradable and biocompatible to minimize the possibility
Hädrich, Gabriela +14 more
openaire +2 more sources
Background: Lipid nanocarriers have been widely tested as drug delivery systems to treat diseases due to their bioavailability, controlled release, and low toxicity. For the pulmonary route, the Food and Drug Administration favors the use of substances generally recognized as safe, as well as biodegradable and biocompatible to minimize the possibility
Hädrich, Gabriela +14 more
openaire +2 more sources